This has been focused strictly on the medical market, and not the recreational market. The stock is below where it was issued last December, probably because they have not talked about a recreational strategy.
CanniMed Therapeutics is a Canadian stock, trading under the symbol CMED-T on the Toronto Stock Exchange (CMED-CT). It is usually referred to as TSX:CMED or CMED-T
In the last year, there was no coverage of CanniMed Therapeutics published on Stockchase.
CanniMed Therapeutics was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for CanniMed Therapeutics.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of CanniMed Therapeutics published on Stockchase.
On , CanniMed Therapeutics (CMED-T) stock closed at a price of $.
This has a good advantage in that they have already expanded, and have 7000 kg per year capacity of dried bud, whereas others are planning that. They can go from sales level of about a tenth of that, to a higher level very quickly. Pesticides and contaminants are a big issue, and this company has pharmaceutical grade manufacturing at their Saskatoon facility of 97,000 ft.². They also have a facility in Michigan. They’ve been doing this for a long time. He likes medical more than recreational. He would wait for a lower price.